Gracemed Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.11 M
as on 09-12-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 6.30%
(FY 2017)
- Profit 4.50%
(FY 2017)
- Ebitda 4.50%
(FY 2017)
- Net Worth 55.25%
(FY 2017)
- Total Assets 1.09%
(FY 2017)
About Gracemed Formulations
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Mohd Khan, Syed Husain, and Rashid Husain serve as directors at the Company.
- CIN/LLPIN
U24232UP2007PTC032726
- Company No.
032726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2007
- Date of AGM
28 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gracemed Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syed Husain  | Director | 06-Jul-2010 | Current |
| Mohd Khan | Director | 06-Jul-2010 | Current |
| Rashid Husain | Director | 06-Jul-2010 | Current |
Financial Performance of Gracemed Formulations.
Gracemed Formulations Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 6.3% increase. The company also saw a slight improvement in profitability, with a 4.5% increase in profit. The company's net worth Soared by an impressive increase of 55.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gracemed Formulations?
In 2017, Gracemed Formulations had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gracemed Formulations?
Unlock and access historical data on people associated with Gracemed Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gracemed Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gracemed Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
